循環器ジャーナル69巻4号

2021年10月発行

特集 プレシジョン・メディシン時代における腫瘍循環器学の重要性 Ⅲ章　プレシジョン・メディシン時代における循環器系の予防・診断・治療技術

腫瘍循環器領域における画像診断技術の研究開発と臨床評価

著者： 根岸朋子¹² 根岸一明¹²³

所属機関： ¹シドニー大学 ²タスマニア大学 ³群馬大学大学院医学系研究科循環器内科学

ページ範囲：P.587 - P.593

Point
・画像診断では，何を診たいのかという診断目的により適正にモダリティを選ぶ必要がある．
・CTRCDの診断にはLVEFを用いるが，GLSの有用性も注目されている．

参考文献

1) Plana JC, Galderisi M, Barac A, et al:Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy:a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 15:1063-1093, 2014

2) Moonen M, Oury C, Lancellotti P:Cardiac Imaging:Multimodality Advances and Surveillance Strategies in Detection of Cardiotoxicity. Curr Oncol Rep 19:63, 2017

3) Negishi K, Negishi T, Hare JL, et al:Independent and incremental value of deformation indices for prediction of trastuzumab-induced cardiotoxicity. J Am Soc Echocardiogr 26:493-498, 2013

4) Lambert J, Lamacie M, Thampinathan B, et al:Variability in echocardiography and MRI for detection of cancer therapy cardiotoxicity. Heart 106:817-823, 2020

5) Thavendiranathan P, Wintersperger BJ, Flamm SD, et al:Cardiac MRI in the assessment of cardiac injury and toxicity from cancer chemotherapy:a systematic review. Circ Cardiovasc Imaging 6:1080-1091, 2013

6) Negishi K, Negishi T, Haluska BA, et al:Use of speckle strain to assess left ventricular responses to cardiotoxic chemotherapy and cardioprotection. Eur Heart J Cardiovasc Imaging 15:324-331, 2014

7) Negishi T, Thavendiranathan P, Negishi K, et al, SUCCOUR investigators:Rationale and Design of the Strain Surveillance of Chemotherapy for Improving Cardiovascular Outcomes:The SUCCOUR Trial. JACC Cardiovasc Imaging 11:1098-1105, 2018

8) Thavendiranathan P, Negishi T, Somerset E, et al:Strain-Guided Management of Potentially Cardiotoxic Cancer Therapy. J Am Coll Cardiol 77:392-401, 2021